IXC
Click for more information
0.00% 7.0¢ invex therapeutics ltd

Ann: Notice of Investor Call and Presentation, page-144

  1. ejjwj
    415 Posts.
    lightbulb Created with Sketch. 59
    clock Created with Sketch.
    06/10/21
    11:10
    Post #: 56598168
    The process of "proving the IIH thesis" is conducting the P3 trial. I suggested that we run the P3 and at the same time look at another indication with surplus funds.
    IXC Price at posting: 68.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Dose Escalation Approved in PYC's ADOA Trial Following Safety Review
right-arrow Created with Sketch.
NEWS $2.44 Million R&D Tax Incentive Refund Received by Neurotech to Boost Clinical Development
right-arrow Created with Sketch.
NEWS Metals X Announces 2024 Ore Reserve Update for Renison Tin Operations
right-arrow Created with Sketch.
NEWS Advanced Clinical Chosen as CRO for Phase 3 Osteoarthritis Trial by Paradigm
right-arrow Created with Sketch.
NEWS High-Grade Lithium Unveiled in Drilling at Sayona's North American Lithium Operation
right-arrow Created with Sketch.
NEWS Mesoblast Provides Update on Ryoncil Launch and Future Product Pipeline Milestones
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $5.260M
Open High Low Value Volume
7.0¢ 7.0¢ 7.0¢ $700 10K

Buyers (Bids)

No. Vol. Price($)
1 7731 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 2873 1
View Market Depth
Last trade - 13.07pm 31/01/2025 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.